Receiving postsurgical treatment with immunotherapy may lengthen the time until relapse. Among patients with advanced melanoma, a longer time until disease recurrence was associated with post-recurrence progression and survival benefits, researchers have found. “It essentially means that if you are […]
Longer Time Until Recurrence Associated With Better Melanoma Outcomes Read More »
Dikembe Mutombo died on Sept. 30 from brain cancer. Basketball star Dikembe Mutombo, an NBA Global Ambassador and Naismith Basketball Hall of Famer died on Sept. 30 at the age of 58 from brain cancer, according to an announcement from
NBA Star Dikembe Mutombo Dies of Brain Cancer Read More »
Patient questions regarding prostate cancer were answered by an expert, which included choosing surgeons and treatments. A prostate cancer journey can involve plenty of questions. As part of our patient education efforts, CURE® spoke with Dr. Oliver Sartor, a medical
Prostate Cancer Questions Answered on Surgery, Side Effects and More Read More »
Ann Wilson (left) and Nancy Wilson of Heart, pictured together. Ann Wilson recently completed chemotherapy for cancer, and Heart will tour in 2025. Photo by Jamie McCarthy via Getty Images. Ann Wilson finishes chemo, Heart reschedules tour for 2025. Ann
Ann Wilson of Heart Returns After Chemo, Ryan Reynolds Visits Young Patient and More Read More »
Model Bianca Balti reveals ovarian cancer on social media. About ovarian cancer according to the American Cancer Society: In 2024, approximately 19,680 women will receive an ovarian cancer diagnosis. A woman’s risk of receiving a diagnosis of ovarian cancer in
Swimsuit Model Reveals Ovarian Cancer, Hockey Pro Shares Diagnosis and More Read More »
Sarclisa, a new drug, has been approved by the FDA for treating newly diagnosed, transplant-ineligible multiple myeloma patients, demonstrating a significant reduction in disease progression or death. The Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) with Velcade (bortezomib),
FDA Approves Sarclisa In Newly Diagnosed Transplant-Ineligible Multiple Myeloma Read More »
Did you know protein consumption might affect kidney function in patients with kidney cancer? Read more to find out. From treatment decisions to protein intake, there are plenty of factors for patients with kidney cancer to weigh. Dr. Thomas Hutson,
Kidney Cancer Questions Answered, From Protein Intake to Clinical Trials Read More »
Tagrisso was approved by the FDA for certain patients with stage 3 non-small cell lung cancer. The Food and Drug Administration (FDA) has approved Tagrisso (osimertinib) for adults with locally advanced, unresectable (cannot be surgically removed) stage 3 non-small cell
FDA Approves Tagrisso for Some With Advanced NSCLC Read More »
Patients with lower-risk MDS and anemia may benefit from Reblozyl as standard of care. Image generated by Adobe Firefly. Reblozyl (luspatercept) has become the new standard of care for patients with low-risk myelodysplastic syndromes (MDS) facing anemia (low red blood
Reblozyl May Be ‘The Standard of Care’ Now in Lower-Risk MDS, Anemia Read More »
After receiving a diagnosis of kidney cancer, it’s important to understand aspects, including stage and grade, treatment options and treatment efficacy. A cancer journey brings with it plenty of questions for patients, caregivers and survivors. Dr. Thomas Hutson, chief of
Kidney Cancer FAQs Answered on Treatments, Care Teams and More Read More »
